These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 8623727)
1. Indinavir approved for HIV infection. Am Fam Physician; 1996 May; 53(6):2203. PubMed ID: 8623727 [No Abstract] [Full Text] [Related]
2. Indinavir (Crixivan), Merck protease inhibitor, approved. James JS AIDS Treat News; 1996 Mar; (no 243):1-2. PubMed ID: 11363299 [TBL] [Abstract][Full Text] [Related]
3. FDA approves 2 new protease inhibitors: ritonavir (Norvir) and Crixivan (Indinavir sulfate). Food and Drug Administration. Schouten JT STEP Perspect; 1996; 8(1):7-8. PubMed ID: 11363592 [TBL] [Abstract][Full Text] [Related]
4. FDA notifications. Alternative dosing regimen for atazanavir is approved. AIDS Alert; 2008 Nov; 23(11):129-30. PubMed ID: 19048649 [No Abstract] [Full Text] [Related]
5. FDA approval: tipranavir. Sax PE AIDS Clin Care; 2005 Aug; 17(8):78. PubMed ID: 16193574 [No Abstract] [Full Text] [Related]
6. Two more HIV protease inhibitors approved. Fox JL Nat Biotechnol; 1996 Apr; 14(4):427. PubMed ID: 9669874 [No Abstract] [Full Text] [Related]
12. Viramune cleared for use in combination with protease inhibitors. AIDS Patient Care STDS; 1998 Nov; 12(11):872. PubMed ID: 11362046 [No Abstract] [Full Text] [Related]
14. Getting your space on the magic crixi-van. Gilden D GMHC Treat Issues; 1996 Mar; 10(3):4. PubMed ID: 11363390 [TBL] [Abstract][Full Text] [Related]
15. Two new protease inhibitors approved by FDA. Food and Drug Administration. Folkers G NIAID AIDS Agenda; 1996 Mar; ():4-5. PubMed ID: 11363799 [TBL] [Abstract][Full Text] [Related]
16. New drugs--reports of new drugs recently approved by the FDA. Indinavir. Bioorg Med Chem; 1997 Mar; 5(3):463-4. PubMed ID: 9113322 [No Abstract] [Full Text] [Related]
17. HIV drug now approved for use with protease inhibitors. Nurse Pract; 1998 Oct; 23(10):89. PubMed ID: 9805335 [No Abstract] [Full Text] [Related]